Xenetic Biosciences, Inc. - XBIO
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | History | Added to | 178,509 | 387 | 0.0% | 0.0% | 1 | +149,559 | 516.61% | Q4 2025 | Feb 12, 2026 |
| CITADEL ADVISORS LLC | History | New | 14,879 | 32 | 0.0% | — | 2 | +14,879 | New | Q4 2025 | Feb 17, 2026 |
| DRW Securities, LLC | History | New | 13,824 | 29 | 0.0% | — | 4 | +13,824 | New | Q4 2025 | Feb 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 13,581 | 29 | 0.0% | 0.0% | 3 | +2,897 | 27.12% | Q4 2025 | Feb 09, 2026 |
| Tower Research Capital LLC (TRC) | History | New | 4,012 | 8 | 0.0% | — | 5 | +4,012 | New | Q4 2025 | Feb 17, 2026 |
| JTC Employer Solutions Trustee Ltd | History | No change | 2,700 | 6 | 0.0% | 0.0% | 6 | 0 | 0.0% | Q4 2025 | Feb 10, 2026 |
| CITIGROUP INC | History | New | 1,241 | 2 | 0.0% | — | 7 | +1,241 | New | Q4 2025 | Feb 13, 2026 |
| Sachetta, LLC | History | Closed out | 0 | 0 | — | 0.02% | — | -15,259 | -100.0% | Q4 2025 | Feb 02, 2026 |
| UBS Group AG | History | Closed out | 0 | 0 | — | 0.0% | — | -497 | -100.0% | Q4 2025 | Jan 29, 2026 |
| BANK OF AMERICA CORP /DE/ | History | Added to | 18 | 0 | — | — | — | +6 | 50.0% | Q4 2025 | Feb 17, 2026 |
| SBI Securities Co., Ltd. | History | Closed out | 0 | 0 | — | — | — | -5 | -100.0% | Q4 2025 | Feb 03, 2026 |
| MORGAN STANLEY | History | Reduced | 3 | 0 | — | — | — | -1 | -25.0% | Q4 2025 | May 27, 2026 |
| Darwin Wealth Management, LLC | History | No change | 2 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Jan 22, 2026 |
| Alexis Investment Partners, LLC | History | No change | 25 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Jan 29, 2026 |